Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Electronic Resource  (3)
  • 1990-1994  (3)
  • 1
    ISSN: 1433-2965
    Keywords: Cyclical therapy ; Etidronate ; Osteoporosis ; Postmenopausal osteoporosis ; Postmenopausal osteoporosis therapy ; Treatment of osteoporosis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Forty seven women with postmenopausal osteoporosis and at least one but no more than four vertebral compression fractures received sequential and cyclical therapy with phosphorus and etidronate (p/etid). During the same 2-year period of observation, three other groups of patients received either sodium fluoride (n=12), estrogen replacement therapy (n=12), or vitamin D and calcium (Ca++) alone (n=15). Axial bone mineral density (BMD) was measured by means of dual-photon absorptiometry. Lateral thoracic and lumbar spine radiographs were taken to assess fractures. Bone mineral density increased from baseline during p/etid therapy: Mean 15.7±1.6% (SD) (P〈0.001). During the same time, the patients in the sodium fluoride group showed a comparable increase in their BMD from baseline: mean 15.7±1.1% (P〈0.001). During the first year of therapy, patients in the estrogen replacement group had an increase in their BMD from baseline: mean: 4.6%±1.1% (P〈0.05). No change in BMD was seen in the control group that received vitamin D and Ca++ alone. No patient who received p/etid, sodium fluoride, or estrogen replacement therapy had any new vertebral compression fractures or height loss, whereas in the control group that received vitamin D and Ca++ alone 6 out of 15 had height loss and at least one new vertebral fracture (P〈0.01). p/etid therapy increases BMD in women with postmenopausal osteoporosis comparable to sodium fluoride but without side effects or toxicity and stabilizes vertebral compression fractures.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Journal of materials science 27 (1992), S. 2770-2780 
    ISSN: 1573-4803
    Source: Springer Online Journal Archives 1860-2000
    Topics: Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics
    Notes: Abstract A study has been performed of the oxidation and degassing processes of aluminium-based alloy powders. Oxidation and hydration of gas-atomized metal powders take place during inflight solidification and cooling to room temperature, during collection and keeping in the powder collection box and during transport and storage before consolidation. Under the atomizing conditions, oxidation cannot be prevented. In contact with humid gases (air) the oxide layer on the powder surface takes up water vapour which is physically or chemically bound. A literature study shows that the oxide layer on atomized aluminium powder is amorphous and has a thickness of 2–10 nm depending on the atomizing conditions. The amount of water in the powder is sufficient to form a completely closed hydroxide layer on the outer surface of the powder. The thickness growth of the oxide layer is governed by cation diffusion. Degassing experiments were carried out by heating canned powders in vacuum. The partial pressures of evolved water vapour and hydrogen were registered as a function of temperature at a constant heating rate. Two different alloy powders were used: the first air atomized and containing 1% magnesium (Al-20Si-3Cu-1Mg-5Fe), and the second (Al-9Fe-2Mo-1Zr) magnesium-free powder, atomized by nitrogen. Much work has been done on degassing, but most of it is directed towards industrial applications. The quantitative theoretical description of the degassing phenomenon is still lacking. A new approach aiming at narrowing this gap is presented by employing Wagner's theory of high temperature oxidation of metals. The diffusion coefficient of aluminium cations through the amorphous aluminium oxide layer has been determined in the degassing temperature range by using the experimental data of Hayden et al. The diffusion coefficient of aluminium cations through the Al2O3 layer has also been evaluated from the degassing experiments. The values obtained directly from the degassing experiments are in reasonable agreement with those derived from the oxidation results. It has been concluded that extrapolation of the results obtained from diffusion experiments at high temperatures in aluminium oxides towards the temperature range of degassing cannot explain the formation of hydrogen during this process, even if the surface diffusion coefficient (much higher than lattice diffusion coefficient) is taken into account.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1434-4726
    Keywords: Head and neck cancer ; Chemotherapy ; Radiotherapy ; Prognosis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Treatment results of irradiation as a single treatment for advanced stage IV unresectable head and neck cancer remains uniformly poor and apparently has not changed with the most recent improvements in oncological care. Despite several negative results of randomized studies, neoadjuvant or concomitant chemotherapy and radiotherapy seems to improve the number of complete responses and also the duration of disease-free survival. The present study was designed to determine the feasibility, potential risks and benefits of the two methods of combined treatment and radiotherapy alone on the management of advanced unresectable squamous cell carcinoma of the upper respiratory and digestive system. From 1983 to 1986, 90 patients entered the trial. Thirty patients were randomized to each study group: radiotherapy alone (70 Gy); neoadjuvant chemotherapy (vinblastine, mitomycin, cisplatin, and bleomycin) and radiotherapy; concomitant chemotherapy (cisplatin and bleomycin) and radiotherapy. An increased frequency of complete responses (33%) was seen in patients treated with the two different combinations of chemotherapy and irradiation compared to irradiation alone (10%). However, toxicity was more common in patients treated with the two modalities of combined treatment and there were no differences in overall survival rates (P = 0.706).
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...